Celularity Inc — Director's Dealing 2025

Jul 16, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2025-06-10

Reporting Person: DosSantos Joseph (Interim CFO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.02	2034-05-01	Class A Common Stock (30000)		Direct

Footnotes

F1: This option was granted under the 2021 Plan and vests and becomes exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.